Chartwell Investment Partners’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-8,085	Closed	-$374K	–	427
2022 Q4	$374K	Buy	8,085 +462	+6%	+$21.4K	0.01%	391
2022 Q3	$316K	Buy	7,623 +268	+4%	+$11.1K	0.01%	401
2022 Q2	$439K	Buy	+7,355	New	+$439K	0.02%	398